BEOVU
BEOVU
Approved
DIN Number
02496976
Drug Class
Human
Market Date
May 15, 2020
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496976
AIG Number0162094001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01LA06 BROLUCIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BROLUCIZUMABActive
Strength: 6 MG / 0.05 ML
Monograph: BROLUCIZUMAB